Report copyright - Reference ID: 3641334 · 2014. 10. 9. · (bortezomib) is indicated for the treatment of patients with multiple myeloma. 1.2 Mantle Cell Lymphoma . VELCADE is indicated for the treatment
Please pass captcha verification before submit form